Postprandial Enrichment of Remnant Lipoproteins With ApoC-I in Healthy Normolipidemic Men With Early Asymptomatic Atherosclerosis
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (9) , 1470-1474
- https://doi.org/10.1161/01.atv.0000029972.42487.42
Abstract
Objectives— Recently, we reported that exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease is associated with enrichment of remnant lipoproteins with apolipoprotein C-I (apoC-I). In this study, the number and composition of chylomicron remnants and very low density lipoproteins (VLDLs) were examined in 30 asymptomatic normolipidemic 50-year-old men with and without early carotid atherosclerotic lesions. Results and Methods— Intima-media thickness of the far wall of the common carotid artery was determined by B-mode ultrasound. Triglyceride-rich lipoproteins were subfractionated by density gradient ultracentrifugation and separated into VLDL and chylomicron remnant fractions by immunoaffinity chromatography. The postprandial triglyceridemia and increase in triglyceride-rich lipoprotein particle number (ie, apolipoprotein B concentrations) were not exaggerated in men with early atherosclerosis. In contrast, their large (Svedberg flotation rate 60 to 400) and small (Svedberg flotation rate 20 to 60) chylomicron remnants and VLDL were greatly enriched with apoC-I, and their small chylomicron remnants and VLDL particles were relatively enriched with cholesterol. Moreover, the number of apoC-I molecules on small chylomicron remnants was strongly associated with the degree of atherosclerosis. Conclusions— Early asymptomatic atherosclerosis in normolipidemic men without exaggerated postprandial triglyceridemia is associated with the enrichment of postprandial chylomicron and VLDL particles with apoC-I. Therefore, it is conceivable that the apoC-I content of lipoprotein remnants may serve as an early marker of coronary artery disease risk.Keywords
This publication has 22 references indexed in Scilit:
- Human Apolipoprotein C-I Accounts for the Ability of Plasma High Density Lipoproteins to Inhibit the Cholesteryl Ester Transfer Protein ActivityPublished by Elsevier ,2000
- Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.Journal of Clinical Investigation, 1998
- In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Journal of Clinical Investigation, 1996
- Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.Journal of Clinical Investigation, 1996
- Postprandial lipoproteins and progression of coronary atherosclerosisAtherosclerosis, 1994
- Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.Journal of Clinical Investigation, 1993
- Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4Biochemical and Biophysical Research Communications, 1989
- Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.Journal of Clinical Investigation, 1986
- Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.Journal of Clinical Investigation, 1984
- Lipoprotein fractionation.Journal of Clinical Pathology, 1973